Neurocognitive Development of Children 4 Years After Critical Illness and Treatment With Tight Glucose Control: A Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
CONTEXT: A large randomized controlled trial revealed that tight glucose control (TGC) to age-adjusted normoglycemia (50-80 mg/dL at age <1 year and 70-100 mg/dL at age 1-16 years) reduced intensive care morbidity and mortality compared with usual care (UC), but increased hypoglycemia (≤40 mg/dL) (25% vs 1%). OBJECTIVE: As both hyperglycemia and hypoglycemia may adversely affect the developing brain, long-term follow-up was required to exclude harm and validate short-term benefits of TGC. DESIGN, SETTING, AND PATIENTS: A prospective, randomized controlled trial of 700 patients aged 16 years or younger who were admitted to the pediatric intensive care unit (ICU) of the University Hospitals in Leuven, Belgium, between October 2004 and December 2007. Follow-up was scheduled after 3 years with infants assessed at 4 years old between August 2008 and January 2012. Assessment was performed blinded for treatment allocation, in-hospital (83%) or at home/school (17%). For comparison, 216 healthy siblings and unrelated children were tested. MAIN OUTCOME MEASURES: Intelligence (full-scale intelligence quotient [IQ]), as assessed with age-adjusted tests (Wechsler IQ scales). Further neurodevelopmental testing encompassed tests for visual-motor integration (Beery-Buktenica Developmental Test of Visual-Motor Integration); attention, motor coordination, and executive functions (Amsterdam Neuropsychological Tasks); memory (Children's Memory Scale); and behavior (Child Behavior Checklist). RESULTS: Sixteen percent of patients declined participation or could not be reached (n = 113), resulting in 569 patients being alive and testable at follow-up. At a median (interquartile range [IQR]) of 3.9 (3.8-4.1) years after randomization, TGC in the ICU did not affect full-scale IQ score (median [IQR], 88.0 [74.0-100.0] vs 88.5 [74.3-99.0] for UC; P = .73) and had not increased incidence of poor outcomes (death or severe disability precluding neurocognitive testing: 19% [68/349] vs 18% [63/351] with UC; risk-adjusted odds ratio, 0.93; 95% CI, 0.60-1.46; P = .72). Other scores for intelligence, visual-motor integration, and memory also did not differ between groups. Tight glucose control improved motor coordination (9% [95% CI, 0%-18%] to 20% [95% CI, 5%-35%] better, all P ≤ .03) and cognitive flexibility (19% [95% CI, 5%-33%] better, P = .02). Brief hypoglycemia evoked by TGC was not associated with worse neurocognitive outcome. CONCLUSION: At follow-up, children who had been treated with TGC during an ICU admission did not have a worse measure of intelligence than those who had received UC. TRIAL REGISTRATION: clinicaltrials.gov Identifier NCT00214916.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Capes, S. E., Hunt, D., Malmberg, K., Pathak, P., & Gerstein, H. C. (2001) · Stroke · doi:10.1161/hs1001.096194 · Cited by 1,824
McCowen, K. C., Malhotra, A., & Bistrian, B. R. (2001) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70154-8 · Cited by 1,170 · cited 3×
“The result of the examination was scored normal or abnormal for 8 neurological domains(17,18): (1) interaction/language skills, (2) gross motor function, (3) involuntary movements, (4) reflexes, (5) coordination and balance, (6) fine motor function, (7) cranial nerves, and (8) special senses (sensory, visual, and audi…”
BackgroundHypoglycemia and risk of death in critically ill patients
The NICE-SUGAR Study Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204942 · Cited by 1,009
Prefrontal cortex activation in task switching: an event-related fMRI study
Dove, A., Pollmann, S., Schubert, T., Wiggins, C. J., & Yves von Cramon, D. (2000) · Cognitive Brain Research · doi:10.1016/s0926-6410(99)00029-4 · Cited by 714
Long-term effect of diabetes and its treatment on cognitive function
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa066397 · Cited by 646
Bellinger, D. C., Wypij, D., Kuban, K. C. K., Rappaport, L. A., Hickey, P. R., Wernovsky, G., Jonas, R. A., & Newburger, J. W. (1999) · Circulation · doi:10.1161/01.cir.100.5.526 · Cited by 579
Vlasselaers, D., Milants, I., Desmet, L., Wouters, P. J., Vanhorebeek, I., van den Heuvel, I., Mesotten, D., Casaer, M. P., Meyfroidt, G., Ingels, C., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60044-1 · Cited by 554 · cited 5×
“PELOD first 24 h in ICU, median (IQR)d 11 (2-12) 11 (2-12) .”
InfluentialSelf-citationBellinger, D. C., Wypij, D., Rivkin, M. J., DeMaso, D. R., Robertson, R. L., Dunbar-Masterson, C., Rappaport, L. A., Wernovsky, G., Jonas, R. A., & Newburger, J. W. (2011) · Circulation · doi:10.1161/circulationaha.111.026963 · Cited by 476 · cited 1×
“Learning index (range, 50-150) 93 (67-96) 87 (84-95) .”
Suh, S. W., Gum, E. T., Hamby, A. M., Chan, P. H., & Swanson, R. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30077 · Cited by 419 · cited 4×
“CBCL–total problems (range, 24-100) 53 (44-61) 51 (45-58) .”
InfluentialAn overview of the objectives of and the approaches to propensity score analyses
Heinze, G., & Jüni, P. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr031 · Cited by 379 · cited 8×
“CBCL–internalizing problems (range, 29-100) 48 (41-57) 52 (45-61) 55 (45-61) .”
BackgroundInfluentialTight glucose control in the intensive care unit: Are glucose meters up to the task?
Scott, M. G., Bruns, D. E., Boyd, J. C., & Sacks, D. B. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.117291 · Cited by 162 · cited 4×
“CBCL–total problems (range, 24-100) 47 (40-55) 52 (45-59) 53 (45-59) .”
InfluentialSmith, A. B., Taylor, E., Brammer, M., & Rubia, K. (2004) · Human Brain Mapping · doi:10.1002/hbm.20007 · Cited by 152
Are Motor Inhibition and Cognitive Flexibility Dead Ends in ADHD?
Rommelse, N. N. J., Altink, M. E., de Sonneville, L. M. J., Buschgens, C. J. M., Buitelaar, J., Oosterlaan, J., & Sergeant, J. A. (2007) · Journal of Abnormal Child Psychology · doi:10.1007/s10802-007-9146-z · Cited by 103 · cited 5×
“Socioeconomic status score, median (IQR)e NA NA 35 (24-48) 34 (24-50) .”
BackgroundInfluentialKALFF, A. C., DE SONNEVILLE, L. M. J., HURKS, P. P. M., HENDRIKSEN, J. G. M., KROES, M., FERON, F. J. M., STEYAERT, J., VAN ZEBEN, T. M. C. B., VLES, J. S. H., & JOLLES., J. (2005) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617705050216 · Cited by 71
Cited by
Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002198 · Cited by 1,228
Davis, A. L., Carcillo, J. A., Aneja, R. K., Deymann, A. J., Lin, J. C., Nguyen, T. C., Okhuysen-Cawley, R. S., Relvas, M. S., Rozenfeld, R. A., Skippen, P. W., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002425 · Cited by 670
Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05878-6 · Cited by 606
Early versus late parenteral nutrition in critically ill children
Fivez, T., Kerklaan, D., Mesotten, D., Verbruggen, S., Wouters, P. J., Vanhorebeek, I., Debaveye, Y., Vlasselaers, D., Desmet, L., Casaer, M. P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1514762 · Cited by 558
Self-citationCurley, M. A. Q., Wypij, D., Watson, R. S., Grant, M. J. C., Asaro, L. A., Cheifetz, I. M., Dodson, B. L., Franck, L. S., Gedeit, R. G., Angus, D. C., et al. (2015) · JAMA · doi:10.1001/jama.2014.18399 · Cited by 461
Metadata
- Authors
- Mesotten, D., Gielen, M., Sterken, C., Claessens, K., Hermans, G., Vlasselaers, D., Lemiere, J., Lagae, L., Gewillig, M., Eyskens, B., Vanhorebeek, I., Wouters, P. J., & Van den Berghe, G.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2012-10-24
- Volume
- 308
- Issue
- 16
- Pages
- 1641
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2015765903
- Cited by
- 153
- References
- 14
- FWCI
- 9.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.